Loading...
Regenerative Potential of the Product “CardioCell” Derived from the Wharton’s Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia
In recent years, mesenchymal stem cells (MSCs) have emerged as a promising therapeutic modality in regenerative medicine. They hold great promise for treating civilization-wide diseases, including cardiovascular diseases, such as acute myocardial infarction and critical limb ischemia. MSCs isolated...
Saved in:
| Published in: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6770009/ https://ncbi.nlm.nih.gov/pubmed/31540534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20184632 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|